| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |